These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 21345279
1. Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate? Oudemans-van Straaten HM, Kellum JA, Bellomo R. Crit Care; 2011 Jan 24; 15(1):202. PubMed ID: 21345279 [Abstract] [Full Text] [Related]
2. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults. Gattas DJ, Rajbhandari D, Bradford C, Buhr H, Lo S, Bellomo R. Crit Care Med; 2015 Aug 24; 43(8):1622-9. PubMed ID: 25853591 [Abstract] [Full Text] [Related]
4. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial. Zarbock A, Küllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, Dimski T, Tyczynski B, Jahn M, Mülling N, Mehrländer M, Rosenberger P, Marx G, Simon TP, Jaschinski U, Deetjen P, Putensen C, Schewe JC, Kluge S, Jarczak D, Slowinski T, Bodenstein M, Meybohm P, Wirtz S, Moerer O, Kortgen A, Simon P, Bagshaw SM, Kellum JA, Meersch M, RICH Investigators and the Sepnet Trial Group. JAMA; 2020 Oct 27; 324(16):1629-1639. PubMed ID: 33095849 [Abstract] [Full Text] [Related]
6. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Liu C, Mao Z, Kang H, Hu J, Zhou F. Crit Care; 2016 May 13; 20(1):144. PubMed ID: 27176622 [Abstract] [Full Text] [Related]
8. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW. Am J Kidney Dis; 2012 Jun 13; 59(6):810-8. PubMed ID: 22226564 [Abstract] [Full Text] [Related]
9. [Choice and management of anticoagulation during CRRT]. Ricci D, Panicali L, Cavallari G, Facchini MG, Mancini E. G Ital Nefrol; 2019 Apr 13; 36(2):. PubMed ID: 30983172 [Abstract] [Full Text] [Related]
11. Citrate versus unfractionated heparin for anticoagulation in continuous renal replacement therapy. Liao YJ, Zhang L, Zeng XX, Fu P. Chin Med J (Engl); 2013 Apr 13; 126(7):1344-9. PubMed ID: 23557569 [Abstract] [Full Text] [Related]
12. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta-analysis of randomized controlled trials. Li R, Gao X, Zhou T, Li Y, Wang J, Zhang P. Ther Apher Dial; 2022 Dec 13; 26(6):1086-1097. PubMed ID: 35385216 [Abstract] [Full Text] [Related]
13. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk. Kalb R, Kram R, Morgera S, Slowinski T, Kindgen-Milles D. Ther Apher Dial; 2013 Apr 13; 17(2):202-12. PubMed ID: 23551677 [Abstract] [Full Text] [Related]